| 论文题目 | 作者 | 刊物名称 | 发表年 |
|---|---|---|---|
| S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury | Wang Q, Long G, Luo H, Zhu X, Han Y, Shang Y, Zhang D, Gong R. | Biomed Pharmacother. | 2023 |
| Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry | Wang H, Yang Q, Liu X, Xu Z, Shao M, Li D, Duan Y, Tang J, Yu X, Zhang Y, Hao A, Wang Y, Chen J, Zhu C, Guddat L, Chen H, Zhang L, Chen X, Jiang B, Sun L, Rao Z, Yang H. | Nat Commun. | 2023 |
| HostNet: improved sequence representation in deep neural networks for virus-host prediction | Ming Z, Chen X, Wang S, Liu H, Yuan Z, Wu M, Xia H. | BMC Bioinformatics. | 2023 |
| Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China | Li Y, Wu Z, Yan Y, Shi Y, Huang J, Du H, Du Q, Li Y, Lin Y, Liu D, Lu X. | Int J Infect Dis. | 2023 |
| Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir | Jiang X, Su H, Shang W, Zhou F, Zhang Y, Zhao W, Zhang Q, Xie H, Jiang L, Nie T, Yang F, Xiong M, Huang X, Li M, Chen P, Peng S, Xiao G, Jiang H, Tang R, Zhang L, Shen J, Xu Y. | Nat Commun. | 2023 |
| Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants | Tan S, Zhao J, Hu X, Li Y, Wu Z, Lu G, Yu Z, Du B, Liu Y, Li L, Chen Y, Li Y, Yao Y, Zhang X, Rao J, Gao G, Peng Y, Liu H, Yuan Z, Liu J, Wang Q, Hu H, Gao X, Zhou H, Yu H, Xu Y, Yu W, Feng L, Wang M, Shan C, Lu J, Lin J. | Sci Bull (Beijing) | 2023 |
| Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication | Cao Z, Liu C, Peng C, Ran Y, Yao Y, Xiao G, Li E, Chen Z, Chuai X, Chiu S. | Virol Sin. | 2023 |
| Identification of Critical Amino Acids of Coxsackievirus A10 Associated with Cell Tropism and Viral RNA Release during Uncoating | Pei J, Liu RL, Yang ZH, Du YX, Qian SS, Meng SL, Guo J, Zhang B, Shen S. | Viruses. | 2023 |
| Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization | Zhang QY, Zhang HQ, Zhang YN, Zhang ZR, Li XD, Hao MC, Zhang Y, Li JQ, Hu YY, Chen XL, Wang J, Shi YJ, Deng CL, Chen JJ, Ye HQ, Zhang B. | Antiviral Res. | 2023 |
| Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner | Jiang X-M, Xin Q-L, Liu K, Peng X-F, Han S, Zhang L-Y, Liu W, Xiao G-F, Li H, Zhang L-K. | mBio. | 2023 |
| Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults | Chen GL, Yu XY, Luo LP, Zhang F, Dai XH, Li N, Shen ZW, Wu KQ, Lou DF, Peng CG, Jin TH, Huang YM, Shao X, Liu Q, Jiang Q, Guo T, Cao F, Zhu JR, Wu XH, Pei RJ, Deng F, Jiang GP, Li YH, Gao HN, He JX, Zhong-Chen, Peng YC, Li LJ. | Vaccine | 2023 |
| Hsp90 β is Critical for the Infection of Severe Fever with Thrombocytopenia Syndrome Virus | Wang B, Zhang L, Deng F, Hu Z, Wang M, Liu J. | Virol Sin. | 2023 |
| Epidemiological surveys revealed the risk of TAMV spill-over from ticks to hosts | Moming A, Bai Y, Chen S, Wu Q, Wang J, Jin J, Tang S, Sun S, Zhang Y, Shen S, Deng F. | Infect Dis (Lond). | 2023 |
| Investigation into the role of the MITA-TRIM38 interaction in regulating pyroptosis and maintaining immune tolerance at the maternal-fetal interface | Liu J, Deng Y, Wang A, Liu B, Zhou X, Yin T, Wang Y, Tang T, Qiu Y, Chen J, Yang J. | Cell Death Dis. | 2023 |
| Characterization of a thermostable Cas12a ortholog | Wu J, Gao P, Shi Y, Zhang C, Tong X, Fan H, Zhou X, Zhang Y, Yin H. | Cell Insight | 2023 |
| Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication | Ma L, Zheng H, Ke X, Gui R, Yao Z, Xiong J, Chen Q. | Virol Sin. | 2023 |
| Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants | Wu Y, Shi J, He X, Lu J, Gao X, Zhu X, Chen X, Zhang M, Fang L, Zhang J, Yuan Z, Xiao G, Zhou P, Pan X. | J Virol. | 2023 |
| Integrative transcriptome analysis reveals alternative polyadenylation potentially contributes to GCRV early infection | Tan S, Zhang J, Peng Y, Du W, Yan J, Fang Q. | Front Microbiol. | 2023 |
| Tyrosine phosphorylation of IRF3 by BLK facilitates its sufficient activation and innate antiviral response | Li WW, Fan XX, Zhu ZX, Cao XJ, Zhu ZY, Pei DS, Wang YZ, Zhang JY, Wang YY, Zheng HX. | PLoS Pathog. | 2023 |
| Chrysin 7-O-β-D-glucuronide, a dual inhibitor of SARS-CoV-2 3CLpro and PLpro, for the prevention and treatment of COVID-19 | Yi Y, Yu R, Xue H, Jin Z, Zhang M, Bao YO, Wang Z, Wei H, Qiao X, Yang H. | Int J Antimicrob Agents | 2023 |
科研成果